Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose

PURPOSE: To investigate the influence of inhomogeneity corrections on stereotactic treatment plans for non-small cell lung cancer and determine the dose delivered to the PTV and OARs. MATERIALS AND METHODS: For 26 patients with stage-I NSCLC treatment plans were optimized with unit density (UD), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuring, Danny, Hurkmans, Coen W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515326/
https://www.ncbi.nlm.nih.gov/pubmed/18662379
http://dx.doi.org/10.1186/1748-717X-3-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515326/
https://www.ncbi.nlm.nih.gov/pubmed/18662379
http://dx.doi.org/10.1186/1748-717X-3-21

Ejemplares similares